id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3811037,c7c44c6d-f572-48ca-bf5a-d31dddd4cf59,Q1,ACORN CONSULTING,401107972,"THORAGENIX INNOVATIONS, INC.",2026,first_quarter,MED,Advancing study and approval for medical devices,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2026-04-15T22:14:54-04:00